(HealthDay News) — Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a research letter published online Feb. 10 in the Journal of the American Medical Association.
From a pool of over 2 million women of reproductive age, users of most methods of hormonal contraception -- including ...